Epizyme (EPZM) Tops Q4 EPS by 19c

Epizyme (NASDAQ: EPZM) reported Q4 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $8 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Titan Machinery (TITN) Misses Q2 EPS by 5c ; Offers Guidance
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance